Doxazosin (Compound)

Synonyms:doxazosin, 74191-85-8, Doxazosine, Doxazosinum, Doxazosina, R-Doxazosin, Doxazosin (INN), [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone, UK 33274, UK-33274, 1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin, 1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin, CHEBI:4708, (RS)-2-{4-[(2,3-Dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine, C02CA04, NW1291F1W8, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone, Doxazosine [French], Doxazosinum [Latin], DOXAZOSIN [INN], Doxazosina [Spanish], Doxazosin [INN:BAN], Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-, 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine, Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-, Cardura XL (TN), supress, UNII-NW1291F1W8, METHANONE, (4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL)(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-, (S)-, 2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine, CPD000097306, DOXAZOSIN [MI], Prestwick0_000858, Prestwick1_000858, Prestwick2_000858, Prestwick3_000858, DOXAZOSIN [VANDF], ChemDiv2_005017, CHEMBL707, EC 616-059-6, DOXAZOSIN [WHO-DD], (+/-)-DOXAZOSIN, Lopac0_000474, Oprea1_259518, SCHEMBL34111, BSPBio_000875, 2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine, SPBio_002796, BPBio1_000963, GTPL7170, DTXSID7022964, BDBM86731, HMS1383E01, HMS2090C20, HMS3259N21, HMS3372L09, HMS3886J03, BCP12228, HY-B0098, ZCA19185, (4-Benzylmorpholin-2-yl)-aceticacid, NSC768144, NSC768145, s5782, AKOS001681453, AKOS017343634, CCG-118218, CS-1831, DB00590, NC00685, NSC-768144, NSC-768145, SDCCGSBI-0050459.P003, IDI1_003732, NCGC00018158-02, NCGC00018158-03, NCGC00018158-05, NCGC00018158-06, NCGC00018158-08, NCGC00018158-11, NCGC00018158-20, NCGC00089775-02, 2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine, AC-11062, AS-77104, SBI-0050459.P002, CAS_74191-85-8, DB-055848, UK 33,274, FT-0630831, UK-3327427, EN300-53055, C06970, D07874, A838054, L000738, Q419939, BRD-A13188892-066-03-3, BRD-A13188892-066-13-2, (4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL)(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHANONE, (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydro-1,4-benzodioxin-2-yl)methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methanone, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(1,4-BENZODIOXAN-2-YLCARBONYL)PIPERAZINE, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazine, 137888-77-8, 2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxy-3,4-dihydroquinazolin-4-imine
Pubchem:PUBCHEM:3157
Id:29287f00-71f3-5dae-a744-01bbe86e7d2d
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Doxazosin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Doxazosin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Doxazosin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.